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Abstract
Background: Effective malaria case-management based on artemisinin-based combination therapy (ACT) and
parasitological diagnosis is a major pillar within the 2007-2012 National Malaria Strategic Plan in the Sudan. Three
years after the launch of the strategy a health facility survey was undertaken to evaluate case-management
practices and readiness of the health facilities and health workers to implement a new malaria case-management
strategy.
Methods: A cross-sectional, cluster sample survey was undertaken at public health facilities in 15 states of Sudan.
Data were collected using quality-of-care assessment methods. The main outcomes were the proportions of
facilities with ACTs and malaria diagnostics; proportions of health workers exposed to malaria related health
systems support activities; and composite and individual indicators of case-management practices for febrile
outpatients stratified by age, availability of ACTs and diagnostics, use of malaria diagnostics, and test result.
Results: We evaluated 244 facilities, 294 health workers and 1,643 consultations for febrile outpatients (425 < 5
years and 1,218 ≥ 5 years). Health facility and health worker readiness was variable: chloroquine was available at
only 5% of facilities, 73% stocked recommended artesunate and sulfadoxine/pyrimethamine (AS+SP), 51% had the
capacity to perform parasitological diagnosis, 53% of health workers had received in-service training on ACTs, 24%
were trained in the use of malaria Rapid Diagnostic Tests, and 19% had received a supervisory visit including
malaria case-management. At all health facilities 46% of febrile patients were parasitologically tested and 35% of
patients were both, tested and treated according to test result. At facilities where AS+SP and malaria diagnostics
were available 66% of febrile patients were tested and 51% were both, tested and treated according to test result.
Among test positive patients 64% were treated with AS+SP but 24% were treated with artemether monotherapy.
Among test negative patients only 17% of patients were treated for malaria. The majority of ACT dispensing and
counseling practices were suboptimal.
Conclusions: Five years following change of the policy from chloroquine to ACTs and 3 years before the end of
the new malaria strategic plan chloroquine was successfully phased out from public facilities in Sudan, however, an
important gap remained in the availability of ACTs, diagnostic capacities and coverage with malaria case-
management activities. The national scale-up of diagnostics, using the findings of this survey as well as future
qualitative research, should present an opportunity not only to expand existing testing capacities but also to
implement effective support interventions to bridge the health systems gaps and support corrective case-
management measures, including the discontinuation of artemether monotherapy treatment.
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Effective case-management based on parasitological diag-
nosis and artemisinin-based combination therapy (ACT) is
one of the key strategies for the reduction of the Plasmo-
dium falciparum malaria burden across the African conti-
nent [1]. By 2009, all 42 African malaria endemic
countries had changed their policies to support ACT use
for uncomplicated malaria. Furthermore, 20 countries had
adopted policies promoting all-age group parasitological
diagnosis using malaria microscopy and rapid diagnostic
tests (RDTs) [2]. Policies in other African countries are
under the revision to support parasitological diagnosis.
However, the implementation of effective case-manage-
ment based on malaria diagnostics and ACTs may face a
number of challenges, of which availability of commodities
at health facilities and sub-optimal case-management
practices are of particular concern. At facilities across
Africa it has been shown that ACTs and malaria diagnos-
tics are frequently out of stock [3,4], where diagnostics
exist, febrile patients are rarely tested [5-9] and if tested,
negative results still result in the prescription of anti-
malarials [5,6,9-14]. Furthermore, the use of non-recom-
mended antimalarials is often reported [8,15-18] and the
performance of patients’ counseling and drug dispensing
tasks is rarely optimal [15,17-19]. Failure to ensure the
delivery of basic commodities and minimum standards of
case-management based on testing and adherence to test
results severely compromises the cost-benefit of new
malaria case-management strategies [20].
In 2004 Sudan was among the first countries in Africa to
change first and second line treatment policy for uncom-
plicated malaria from ineffective monotherapies to ACTs
[21-23]. The first line policy was changed from chloro-
quine to a combination of artesunate and sulfadoxine/pyri-
methamine (AS+SP) and the second line policy was
changed from SP to artemether-lumefantrine (AL). For
severe malaria parenteral quinine remained the treatment
of choice and intramuscular artemether was recom-
mended as second line therapy [24]. Following change of
the policy, SP monotherapy was only reserved for inter-
mittent preventive treatment in pregnant women in
selected high risk areas.
In 2006, the Sudanese National Malaria Control Pro-
gramme (NMCP) launched the new 2007-2012 National
Malaria Strategy which reconfirmed ACT treatment pol-
icy and provided strategic directions to ensure universal
access to ACTs and malaria confirmatory diagnosis pri-
marily through microscopy, or RDTs wherever malaria
microscopy is not possible [25]. Between 2005 and 2009
the Federal NMCP supported the implementation of the
new treatment policy across the 15 states of Sudan. The
key implementation activities of relevance for ACT
based case-management at the facility level included
procurement and distribution of co-packaged AS+SP in
paediatric (50 mg AS+500/25 mg SP) and adult (100 mg
AS+500/25 SP) formulations, procurement and distribu-
tion of co-formulated AL in four weight-specific
packages, development and dissemination of treatment
protocols and job aids for health workers, orientation
sessions and in-service case-management trainings for
all cadres of health workers and strengthening of diag-
nostic capacities for the parasitological diagnosis of
malaria. With respect to malaria diagnostics it should be
acknowledged that despite the fact that confirmatory
diagnosis is one of the key strategic case-management
orientations of the Sudanese 2007-2012 National
Malaria Strategy [25], by the time of this study malaria
diagnostic capacities in the country relied mainly on the
presence of malaria microscopy while only limited quan-
tities of RDTs were delivered to lower level facilities
without microscopy support.
In this report we present data on the availability of case-
management commodities, coverage with malaria related
health systems support activities and the malaria case-
management practices across the Sudan 5 years after the
policy change and 3 years after the launch of the national
malaria strategy.
Methods
Survey design
T h es u r v e yd e s i g nw a sac r o s s - s e c t i o n a l ,c l u s t e rs a m p l e ,
health facility survey undertaken in government and non-
government public health facilities in 15 states of Sudan.
Private health facilities were not included in the survey
because they are not supplied with ACTs and malaria
diagnostics by the Federal Ministry of Health. The survey
was undertaken between 9
th and 31
st December 2009. The
sample size was calculated at patient level assuming 50%
prevalence of the primary case-management indicator,
95% confidence level, desired precision of +/- 7%, design
effect of 2 and the likelihood that 50% of health facilities
would not have either malaria diagnostics or ACTs in
stock. Based on these parameters, an estimated sample
size was 728 outpatient consultations in each age group
(below and above 5 years of age) or estimating that on
average 3 febrile patients can be recruited in each age
group at each facility over one survey day, then the
required number of surveyed facilities was 243 (728/3).
From the universe of 5,716 public health facilities in
Sudan a stratified random sample taking into considera-
tion within-country distribution of facilities by state (15
strata) and type of facilities within a state (3 strata) was
drawn to ensure national representativeness. For each of
45 strata we calculated a sampling fraction within the uni-
verse of 5,716 facilities, proportional and effective sample
size within the required sample of 243 facilities, and finally
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final effective sample size contained one additional facility
because of rounding off to the proportional sample size. A
cluster was defined as all outpatients’ encounters between
a health worker and patients occurring on a single survey
day.
Data collection
Data were collected by 72 field workers trained during 5
days until agreement of practice results between field
workers and trainers was greater than 90%. In total, 36
teams were created, each composed of two field workers.
The field work was supervised by 15 state coordinators
who were also trainers of field workers. Three methods
were used to collect data during a survey day at health
facility. First, all patients presenting to the outpatient
departments underwent rapid screening when they were
ready to leave the facility. After obtaining written informed
consent non-referred and non-pregnant patients aged 2
months and older, weighing 5 kg and above and present-
ing for an initial outpatient visit with fever were inter-
viewed. Detailed information about patients’ age, weight,
temperature, prior use of antimalarial drugs, routine
malaria diagnostics performed and results reported, medi-
cations prescribed and the key counseling and drug dis-
pensing tasks performed during the facility visit was
collected during the interviews and from the patient-held
cards. Second, each health facility was assessed to deter-
mine availability of basic infrastructure, equipment, job
aids, antimalarial drugs, malaria RDTs and functional
malaria microscopy service. Finally, all health workers who
attended to recruited patients on the survey day were
interviewed at the end of the survey day to determine
their demographics, pre-service and in-service training,
access to treatment protocols and exposure to supervision
in the preceding 6 months. Verbal informed consent was
obtained from all health workers prior to the commence-
ment of study procedures.
Indicators and definitions
The key study indicators referred to the availability of
malaria case-management commodities, health workers
coverage with ACT related interventions and the malaria
case-management practices which are deemed critical to
the success of the AS+SP based case-management policy.
The primary indicators at health facility level referred to
the proportions of facilities with ACTs, other antimalar-
ials, job aids and malaria diagnostic services on the sur-
vey day. At the health worker level the primary indicators
were the proportions of health workers who received
training on malaria case-management, who had access to
national treatment protocols and who were exposed to
supervisory visits including malaria case-management in
past 6 months.
At the patient level primary indicators referred to febrile
patients for whom malaria testing was merited and AS+SP
treatment should have been considered in relation to the
result of malaria test. With respect to testing indications,
we included all patients with fever because national
malaria guidelines are ambiguous and do not specify cri-
teria defining other obvious causes of fever (Figure 1).
Therefore our analysis included febrile, non-pregnant
patients aged 2 months and older, weighing 5 kg and
above and presenting for an initial outpatient visit without
being referred or admitted for hospitalization. Fever was
defined as axillary temperature of ≥ 37.5°C or the history
of fever during the present illness. A health workers deci-
sion to refer or admit patient for hospitalization was used
as proxy measure to define severity of disease and exclude
patients with suspected severe disease meriting treatment
with other drugs than AS+SP. The primary outcome was a
composite case-management indicator and included per-
formance of all of the following three tasks: 1) patient was
tested for malaria; 2) if positive test result patient was trea-
ted with AS+SP, and 3) if negative test result patient was
not treated for malaria. Despite some ambiguity of the
guidelines with respect to the treatment of patients with
test negative results (Figure 1), the absence of antimalarial
treatment for these patients was included in the definition
of the composite case-management indicator because
treatment of test negative patients was considered as one
of the major determinants undermining the new case-
management policy. The secondary outcomes reflected
individual components of the case-management including
testing, treatment, dispensing and counseling practices in
various patients’ subgroups.
Data management and analysis
Data were double entered by independent data entry
clerks using Access 2007 (Microsoft Inc., Redmond, WA,
USA). Data files were compared for errors using a verifica-
tion programme and referring to original questionnaires.
The analysis was performed using STATA, version 11
(StataCorp, College Station, TX, USA). Descriptive analysis
was undertaken at the health facility, health worker, and
patient level across all age groups and stratified for chil-
dren below 5 years of age and patients 5 years and older.
The presentation of the results reflected the main objec-
tive of the study, i.e. to provide national level data for
which the study was sufficiently powered to obtain infor-
mation with desired precision. A stepwise approach was
applied in the analysis of malaria case-management prac-
tices. First, to evaluate progress of 2007-2012 national
malaria strategy health workers practices are analyzed at
all health facilities regardless of the availability of the case-
management commodities. Second, to evaluate health
workers adherence to the new policy the same analysis
was restricted to the facilities where AS + SP and malaria
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quality of AS + SP dispensing and counseling practices
was restricted to patients who had AS + SP prescribed and
dispensed at facility. The precision of proportions (95%
confidence interval [CI]) was determined adjusting for the
cluster sampling at health facility level. Cluster adjusted
chi-square test was used to compare proportions between
patients below and above 5 years of age.
Ethical approval
Ethical clearance for the study was obtained from the
National Research Ethics Committee of the Federal Min-
istry of Health in Sudan (reference number 114-11-09).
Results
Sample description
The survey was undertaken at 244 health facilities (Fig-
ure 2) where 294 health workers performed 4,140 outpa-
tient consultations on the survey days. All 244 facilities
were assessed and all 294 health workers were
interviewed. Of the 4,140 screened patients, the case-
management practices were evaluated for 1,707 non-
pregnant febrile patients weighing 5 kg and above and
presenting for an initial outpatient visit. The remaining
2,433 patients (some patients may have had more than
one exclusion criteria) were patients either referred
(197) or admitted for hospitalization (61), pregnant
women (362), follow up visits (420), aged less than 2
months (50), weighing less than 5 kg (41) and patients
presenting without fever (1,365). Further 64 patients had
incomplete data preventing analysis of the case-manage-
ment practices. Therefore our analysis included 1,643
patients of which 425 (25.9%) were below 5 years of age
and 1,218 (74.1%) were 5 years and older. At facilities
with available AS+SP and malaria diagnostics on the
survey day health workers’ adherence was evaluated for
961 patients, of which 252 (26.2%) patients were below
5 years of age and 709 (73.8%) were 5 years and older.
No health worker, adult patient or caretaker on behalf
of sick child refused to participate in the study.
Figure 1 The general plan for malaria diagnosis and treatment in Sudan.
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ACT policy
Of the 244 health facilities assessed, most were basic
health units (63.9%) followed by health centres (29.1%)
(Table 1). The large majority (88.9%) of facilities were
government owned. Nearly half (49%) had electricity,
while water from any source was available at 72.1% of
facilities on the survey day. A functional weighing scale
was present at 58% of facilities while about half had
functional thermometer (48.8%) and displayed new
treatment protocol either in the format of wall or table
charts (51.2%). Malaria parasitological diagnosis was
provided at 125 (51.2%) facilities on the survey day,
more commonly through malaria microscopy (42.2%)
than non-expired RDTs (16.0%). Seventeen health facil-
ities had both diagnostic capacities. Parasitological capa-
city to diagnose malaria was available in all hospitals
(17/17), 79% (56/71) of health centres and 33% (52/156)
of basic health units. Of interest, 12% of basic health
units, 23% of health centres and 24% of hospitals had
non-expired RDTs in stock. Only 13 (5%) facilities
stocked expired RDTs.
Any non-expired blister packs of AS+SP tablets (50 or
100 mg) were in stock at 73.4% of facilities (Table 1).
Conversely, expired blisters of AS+SP were found at
only seven (2.9%) facilities. Non-recommended chloro-
quine was available at 11 (4.5%) facilities. At 88 health
centres and hospitals injectable formulations of quinine
and artemether were respectively available at 54.5% and
77.3% of facilities. Finally, at the same facilities at least
one of the four AL weight-specific packs was in stock at
only 24.6% of facilities.
Of 294 health workers who performed consultations on
the survey day (Table 2), most were male (82.7%) and the
most common cadres were medical assistants (43.9%), fol-
lowed by doctors (26.9%) and nurses (12.6%). Doctors were
the most common outpatient health workers at hospitals
(67%) and health centres (52%) and the least common
Figure 2 The map of the 15 states of Sudan showing the 244 surveyed health facilities.
Abdelgader et al. BMC Public Health 2012, 12:11
http://www.biomedcentral.com/1471-2458/12/11
Page 5 of 12cadre at basic health units (6%). Over half of the health
workers (52.7%) were trained on ACT use, most commonly
through the NMCP in-service training programme (127/
155; 81.9%). Besides the formal in-service training, brief
orientation on ACT policy was provided for 42.2% of
health workers. Only 23.5% of outpatient health workers
were trained on RDT use. Less than half (39.7%) of health
workers had access to either personal or a facility copy of
national malaria treatment protocol. Finally 35.7% of out-
patient health workers had received a supervisory visit in 6
months prior to the survey, and only 19.4% received a visit
that included any activity on malaria case-management
(Table 2).
Malaria diagnostic and treatment practices
Of 1,643 suspected malaria patients, 52.6% were female
and the mean age of the patients was 19 years. Only
39.9% of the patients reported to the facility within two
days of the febrile illness, more commonly children
below 5 years (45.4%) than patients 5 years and older
(38.0%). Of greater concern was that 10.1% of children
and 18.4% of patients 5 years and older reported to the
facility seven or more days after the beginning of the ill-
ness. Only 4.0% of patients had taken any antimalarial
drug prior to the facility visit and only 19 (1.2%) patients
had taken AS+SP. Axillary temperature ≥ 37.5°C was in
28.7% of patients, more commonly among children
below 5 years of age (38.4%) than in patients 5 years and
older (25.4%). Health workers commonly determined age
of the patients (70.1%) while weight (8.9%) and tempera-
ture (3.0%) were rarely measured.
Overall, at all 244 study facilities 34.5% of febrile
patients (35.3% of children vs 34.2% of patients 5 years
and older; p = 0.723) were managed according to the
Table 1 Characteristics of surveyed health facilities in Sudan
Health facility characteristics (N = 244) n % 95% CI
Health facility type
Basic Health Unit 156 63.9 57.9-70.0
Health Centre 71 29.1 23.4-34.8
Hospital 17 7.0 3.8-10.2
Health facility ownership
Government 217 88.9 85.0-92.9
Non-governmental organization 27 11.1 7.1-15.0
Basic infrastructure and equipment at health facility
Water available 176 72.1 66.4-77.8
Electricity available 119 48.8 42.4-55.1
Functional weighing scale available 142 58.2 52.6-65.2
Functional thermometer available 119 48.8 43.6-56.4
Treatment protocol chart exposed 125 51.2 46.1-58.9
Availability of malaria diagnostics on survey day
Functional microscopy service 103 42.2 35.9-48.4
Non-expired Malaria Rapid Diagnostic Tests (RDT) 39 16.0 11.3-20.6
Any functional diagnostic service (microscopy or RDTs) 125 51.2 44.9-57.5
Availability of non-expired ACTs on the survey day
Any blister pack tablets of AS+SP 179 73.4 67.7-78.9
AS+SP (50 mg AS pack) 164 67.2 61.2-73.1
AS+SP (100 mg AS pack) 158 64.7 58.7-70.7
Artemether-lumefantrine (at least one pack)
a 22 24.6 21.3-28.6
Any ACT in stock (any pack of AS+SP or AL) 181 74.2 68.7-79.7
Availability of other antimalarials on the survey day
SP tablets 85 34.8 28.8-40.8
Quinine tablets 85 34.8 28.8-40.8
Quinine injections
a 48 54.5 43.9-65.2
Artemether injections (40 or 80 mg)
a 68 77.3 68.3-86.2
Chloroquine (any formulation) 11 4.5 1.9-7.1
aAnalysis for these indicators restricted to 88 health centres and hospitals which are supposed to stock these items
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tested for malaria and treated with AS+SP if the test
result was positive or not treated for malaria if the test
result was negative. At these facilities 45.8% of febrile
patients were tested without significant difference between
age groups (43.8% vs 46.5%; p = 0.425) (Table 3). Among
752 tested patients, the test positivity rate was 40.3%, with
no significant difference between children and patients 5
years and older (38.7% vs 40.8%; p = 0.647). Most patients
tested (93.4%; 702/752) had microscopy performed.
Among test positive patients, 62.7% of patients were trea-
ted with AS+SP, yet a substantial proportion (25.7%)
received intramuscular artemether. Children below 5 years
of age were more commonly treated with AS+SP (70.8% vs
60.2%; p = 0.116) while patients 5 years and older were
more commonly treated with injectable artemether (28.6%
vs 16.7%; p = 0.056). Furthermore, despite the overwhelm-
ing adherence to test negative results 15.3% of test negative
patients were treated for malaria - 13.2% of children and
17.0% of patients 5 years and older (p = 0.336) (Table 3).
Compared to the practices observed at all 244 health
facilities, some of the indicators significantly improved at
107 (43.9%) facilities where malaria diagnostic services
(microscopy or RDTs) and AS+SP were available on the
survey day. The composite case-management perfor-
mance increased from 34.5% to 50.5% while testing rates
Table 2 Characteristics of outpatient health workers in Sudan
Health worker characteristics (N = 294) n % 95% CI
Male health worker 243 82.7 78.3-87.0
In-charge of health facility 193 66.3 61.0-71.8
Pre-service training
Doctor 79 26.9 21.8-32.0
Medical assistant 129 43.9 38.2-49.6
Nurse 37 12.6 8.8-16.4
Community Health Worker 37 12.6 8.8-16.4
Other cadres 12 4.1 1.8-6.4
In-service training on malaria case-management
Any training based on ACT policy 155 52.7 46.9-58.4
NMCP training 127 43.2 37.5-48.9
IMCI training 71 24.1 19.2-29.1
Malaria RDT training 69 23.5 18.6-28.3
Brief ACT orientation 124 42.2 36.5-47.9
Access to guidelines
Malaria treatment booklet 117 39.7 34.2-45.4
Exposure to supervision
Any supervisory visit in past 6 months 105 35.7 30.2-41.2
Supervisory visit including malaria case-management 57 19.4 14.8-23.9
Table 3 Malaria diagnostic and treatment practices for febrile patients at all 244 surveyed facilities in Sudan
Children < 5 yrs N = 425 Patients ≥ 5 yrs N = 1218 P-value All age groups
N = 1643
n (%) n (%) n (%) 95% CI
Correctly managed
a 150 (35.3) 417 (34.2) 0.723 567 (34.5) 29.3-39.7
Malaria test performed 186 (43.8) 566 (46.5) 0.425 752 (45.8) 39.0-52.6
Treatment for test positive patients N = 72 N = 231 N = 303
AS+SP 51 (70.8) 139 (60.2) 0.116 190 (62.7) 55.6-69.9
Artemether injection 12 (16.7) 66 (28.6) 0.056 78 (25.7) 19.6-31.8
Other antimalarials
b 4 (5.6) 10 (4.3) 0.754 14 (4.6) 1.1-8.2
No AM prescribed 5 (6.9) 16 (6.9) 0.995 21 (6.9) 3.5-10.4
Treatment for test negative patients N = 114 N = 335 N = 449
AS+SP 11 (9.6) 46 (13.7) 0.303 57 (12.7) 6.3-17.7
Artemether injection 3 (2.6) 8 (2.4) 0.874 11 (2.5) 1.0-3.9
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66.8% of patients tested. Interestingly, at these facilities
where AS+SP was in stock, the pattern of treatment prac-
tices for test positive and test negative patients showed
only minor changes compared to observations at all
health facilities (Tables 3 and 4).
Quality of ACT dispensing and counseling
The performance of five dispensing and counseling tasks
was evaluated for 347 patients who had AS+SP prescribed
and dispensed at health facilities (Table 5). The majority
of the patients were explained how to take AS+SP drugs at
home (86.5%) and advised to complete all AS+SP doses
Table 3 Malaria diagnostic and treatment practices for febrile patients at all 244 surveyed facilities in Sudan
(Continued)
Other antimalarials
c 1 (0.9) 3 (0.9) 0.986 4 (0.9) 0-1.7
Any AM prescribed 15 (13.2) 57 (17.0) 0.336 72 (16.0) 9.3-21.3
No AM prescribed 99 (86.8) 278 (83.0) 0.336 377 (84.0) 77.9-90.0
Treatment when test not done N = 239 N = 652 N = 891
AS+SP 40 (16.7) 193 (29.6) 0.002 233 (26.2) 19.5-32.8
Artemether injection 4 (1.7) 32 (4.9) 0.049 36 (4.0) 1.7-6.3
Other antimalarials
d 6 (2.5) 11 (1.7) 0.251 17 (1.9) 0.6-3.2
No AM prescribed 189 (79.1) 416 (63.8) 0.001 605 (67.9) 60.9-74.9
aDefined as performance of all of the following three tasks: 1) patient tested for malaria; 2) if positive test result treated with AS+SP, and 3) if negative test result
not treated for malaria.
bOther antimalarial treatments include: SP (5), QN (5) and AL (4)
cOther antimalarial treatments include: SP (3), QN (1)
dOther antimalarial treatments include: SP (5), QN (7) and CQ (5)
Table 4 Malaria diagnostic and treatment practices for febrile patients at 117 facilities with available AS + SP and
malaria diagnostic services on survey days in Sudan
Children < 5 yrs N = 252 Patients ≥ 5 yrs N = 709 P-value All age groups N = 961
n (%) n (%) n (%) 95% CI
Correctly managed
a 120 (47.6) 365 (51.5) 0.325 485 (50.5) 44.5-56.4
Malaria test performed 154 (61.1) 488 (68.8) 0.045 642 (66.8) 59.6-74.0
Treatment for test positive patients N = 59 N = 190 N = 249
AS+SP 40 (67.8) 120 (63.2) 0.519 160 (64.3) 56.3-72.2
Artemether injection 10 (17.0) 50 (26.3) 0.174 60 (24.1) 17.6-30.5
Other antimalarials
b 4 (6.8) 5 (2.6) 0.278 9 (3.6) 0.4-6.8
No AM prescribed 5 (8.5) 15 (7.9) 0.863 20 (8.0) 3.8-12.2
Treatment for test negative patients N = 95 N = 298 N = 393
AS+SP 11 (11.6) 42 (14.1) 0.574 53 (13.5) 7.1-19.8
Artemether injection 3 (3.2) 8 (2.7) 0.791 11 (2.8) 1.1-4.5
Other antimalarials
c 1 (1.1) 3 (1.0) 0.969 4 (1.0) 0-2.0
Any AM prescribed 15 (15.8) 53 (17.8) 0.657 68 (17.3) 10.5-24.1
No AM prescribed 80 (84.2) 245 (82.2) 0.657 325 (82.7) 75.9-89.5
Treatment when test not done N = 98 N = 221 N = 319
AS+SP 8 (8.2) 31 (14.0) 0.278 39 (12.2) 4.4-20.0
Artemether injection 1 (1.0) 5 (2.3) 0.389 6 (1.9) 0-3.7
Other antimalarials
d 1 (1.0) 0 (0) 0.111 1 (0.3) 0-0.9
No AM prescribed 88 (89.8) 185 (83.7) 0.320 273 (85.6) 76.7-94.4
aDefined as performance of all of the following three tasks: 1) patient tested for malaria; 2) if positive test result treated with AS+SP, and 3) if negative test result
not treated for malaria
bOther antimalarial treatments include: SP (3), QN (2) and AL (4)
cOther antimalarial treatments include: SP (3), QN (1)
dOther antimalarial treatments include: SP (1)
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administered at the health facility, 6.1% were weighed and
the advice on what patients should do in case of vomiting
was rarely provided (6.4%). Children below 5 years of age
were more commonly weighed than patients 5 years and
older (13.9% vs 4.0%; p = 0.006) and advice on vomiting
was more commonly provided for children than patients 5
years and older (12.5% vs 4.8%; p = 0.009) (Table 5).
Discussion
Our facility-based evaluation of the malaria case-man-
agement under the ACT policy in the 15 states of
Sudan provides a number of observations relevant for
future implementation activities under the 2007-2012
National Malaria Strategy.
Health systems support to implement ACT based malaria
case-management
The critical pre-requisite for effective implementation of
any treatment policy is universal availability of recom-
mended, non-expired medicines as well as discontinued
provision of obsolete therapies. The findings of this study
revealed that chloroquine monotherapy had largely been
successfully phased out from Sudanese facilities (absent
at 95% of facilities), the presence of expired ACTs was
nearly non-existent (3%) while recommended first-line
therapy (AS+SP) was in stock at 73% of facilities and sec-
ond-line therapy (AL) at only 25% of facilities. The find-
ing that over one-quarter (26%) of facilities stocked no
ACTs on the survey days is worrisome especially in com-
parison with prior studies in Sudan reporting nearly uni-
versal availability of recommended first-line antimalarials
under the chloroquine policy [26,27]. However, the mag-
nitude of ACT stock-outs found in this study is not
unique to Sudan - nearly equal results were recently
reported from Kenya where 25% of public facilities had
ACT stock-outs [3] and similar findings were reported
from Uganda [18]. Future studies evaluating qualitative
and quantitative characteristics of ACT supply chain are
required in Sudan to better understand causes of ACT
stock outs.
The second pre-requisite important for effective imple-
mentation of malaria case-management includes the capa-
city at health facilities to undertake malaria testing. Our
survey revealed that currently about half (51%) of the pub-
lic facilities in Sudan provide malaria diagnostic services,
largely based on microscopy. While the relatively low
availability of malaria diagnostics is understandable at
basic health units (33%) where only limited diagnostic
capacities have been deployed in the past it should be
however noted that parasitological diagnosis was absent at
21% of health centres - the level of care traditionally pro-
viding laboratory support in Sudan. To rapidly increase
the coverage of health facilities with malaria diagnostic
services a focus on large scale procurement and supply of
RDTs accompanied with the quality assurance activities to
those facilities where malaria microscopy service is cur-
rently not available will fill an important gap. Simulta-
neously, at facilities with existent microcopy the
strengthening of the quality of this service is the utmost
priority. The quality assurance activities supporting both,
RDTs and malaria microscopy, will be critical determi-
nants to ensure routine accuracy of RDTs and overcome
deficiencies in the quality of malaria microscopic services
that have been previously reported in Sudan [28,29] as
well as in the region [30,31]
Finally the provision of ACTs and diagnostics requires
a package of health systems support activities for health
workers which are necessary to implement, reinforce and
maintain effective malaria case-management practices.
Our findings revealed gaps in the coverage of health
workers with malaria related health systems support
activities; 47% of outpatient health workers had not
attended ACT based case-management training, 76% had
not been trained in the use of RDTs, 60% had no access
to treatment protocols, 64% had not received any super-
visory visit and importantly only 19% received a visit that
included any activity related to malaria case-manage-
ment. An opportunity to rapidly increase health workers
exposure to these activities lies in the large scale RDT
implementation which should be accompanied with
broader and comprehensive malaria case-management
Table 5 Quality of AS+SP dispensing and counseling in Sudan
Children < 5 yrs N = 72 Patients ≥ 5 yrs N = 275 P-value All age groups
N = 347
n (%) n (%) n (%) 95% CI
Explained dosing schedule 64 (88.9) 236 (85.8) 0.657 300 (86.5) 82.8-90.1
Advised to complete all doses 52 (73.2)
a 158 (57.5) 0.070 210 (60.5)
a 55.5-65.9
Patient weighed 10 (13.9) 11 (4.0) 0.006 21 (6.1) 3.5-8.6
First dose administered at HF 0 (0) 10 (3.6) 0.115 10 (2.9) 1.1-4.6
Explained what to do if vomiting 9 (12.5) 13 (4.8)
b 0.009 22 (6.3)
b 3.8-8.9
aDenominator does not include one patient with missing value
bDenominator does not include two patients with missing values
Abdelgader et al. BMC Public Health 2012, 12:11
http://www.biomedcentral.com/1471-2458/12/11
Page 9 of 12in-service training, dissemination of job aids, post-train-
ing follow up and structured supervisory visits and per-
formance monitoring.
Malaria case-management practices
We have defined correct management of febrile patients
from malaria perspective considering performance of the
three minimum criteria determining success of ACT
based policy based on confirmatory diagnosis [20]. These
included 1) malaria testing, 2) treatment of test positive
results with recommended AS+SP and 3) withdrawal of
antimalarial treatment for test negative patients. Our find-
ings revealed that at all study facilities 35% of febrile
patients are currently managed according to the composite
indicator, with little difference between age groups. At the
same facilities 46% of febrile patients are tested. While
analysis based on all study facilities is useful to evaluate
overall progress of the case-management practices under
the 2007-2012 National Malaria Strategy, it does not con-
sider the absence of ACTs and diagnostics at health facil-
ities - the main determinant precluding case-management
practices. Therefore, to evaluate health workers adherence
to the new policies practices at 117 (48%) facilities where
both, malaria diagnostic services and AS+SP, were avail-
able on the survey day were evaluated separately. At these
facilities health workers performed all three tasks defining
our composite indicator for a significantly higher propor-
tion (51%) of febrile patients compared to analysis based
on all facilities.
There are three levels of discordance contributing to the
non-adherent case-management practices at facilities with
available commodities. First, not all febrile patients are
tested for malaria, however, 67% of patients parasitologi-
cally diagnosed is significantly higher compared to 43%
reported in similar studies in Kenya [32], 40% in Uganda
[12], 31% in Angola [9] 27% in Zambia [5] and 27% in
Tanzania [7]. The possible explanation of higher testing
rates at facilities with malaria diagnostics in Sudan com-
pared to other countries could be due to the presence of
more qualified outpatient staff such as medical doctors
and long term establishment of malaria microscopy in the
country traditionally promoting, wherever possible,
malaria testing across all age groups and malaria endemi-
cities. The future priority for policy implementers in
Sudan should be improvement in testing rates across all
facilities.
The second level of discordance refers to patients with
positive test result where only 64% of patients at facilities
with AS+SP in stock, are treated with recommended first
line therapy for uncomplicated malaria. At these facilities
an important observation was the relatively wide-spread
use of injectable artemether monotherapy, a practice not
promoted globally on the grounds that it might promote
the development of resistance to artemisinine derivatives
[33]. In this category of patients, we also observed ten-
dency towards higher use of oral AS+SP in children
while use of injectable artemether was more common for
older children and adults, the finding reflecting previous
report from Khartoum where irrational injectable therapy
under the chloroquine policy was common and indeed
prevailing in adults [26]. Injectable antimalarials have a
long history in Sudan [26,34] and may be due to a combi-
nation of factors including the lack of appropriate train-
ing of health workers, lack of public education and
patients’ demands and beliefs. Future educational and
supervisory interventions targeting health workers, as
well as those targeting the broader public, should
urgently address the problem of inappropriate use of
injectable artemether.
The third and the lowest level of discordance was the
observation made amongst those patients with a negative
test result who were still treated with an antimalarial
(17%). While this remains imperfect, this level of inap-
propriate prescription is substantially lower than reported
under larger scale evaluations in other national settings
[5,7,10,11,13,35]. Interestingly, this relatively low level of
disregard of negative test results existed despite the ambi-
guity of national guidelines allowing possibility of antima-
larial treatment for test negative patients (Figure 1).
International recommendations have recently changed to
recommend treatment of only test positive patients and
Sudanese guidelines should be also amended along these
lines to facilitate elimination of these irrational practices
(WHO 2010).
Finally, adequate ACT dispensing and counseling prac-
tices deserve attention as these tasks underpin good clini-
cal practice necessary to ensure high rates of patients’
adherence and treatment success [36-38]. In our study we
found that the majority of patients were explained the dos-
ing schedule (87%) and advised to complete the dose
(61%), however, the practices of administering the first
dose of AS+SP at the facility, weighing patients and pro-
viding advice to patients what to do in case of vomiting
was rarely performed (3-6%). Suboptimal dispensing and
counseling practices found in our study concur with the
findings reported previously in Sudan [27,39], as well as
from several studies across Africa [15,19]. The reasons for
these suboptimal practices are not clear and demand
further qualitative research including the potential effects
of lack of potable water on administering drugs at facilities
and the effects of AS+SP blister packages on the provision
of replacement dose in case of vomiting.
Study limitations
Several study limitations should be mentioned. First, the
presence of study teams may have introduced the Haw-
thorn effect resulting in better performance of health
workers on survey days than usual [40,41]. To minimize
Abdelgader et al. BMC Public Health 2012, 12:11
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Page 10 of 12this possibility we restrained from more “invasive” study
procedures such as observation of consultations and
limit patient level data collection only to patient’se x i t
interviews. Second, the evaluation was undertaken from
malaria case-management perspective and did not
include data collection methods such as clinical re-
examinations and direct observations to evaluate clinical
assessment practices for non-malaria febrile patients
which would provide an additional light to some of the
practices. Finally, the appropriate drug dosage compo-
nent of antimalarial treatments was not analyzed due to
high rates of incomplete dosage prescriptions.
Conclusions
Five years following the shift of the Sudanese treatment
policy to ACTs and three years before the end of the
2007-2012 Malaria Strategic Plan the chloroquine mono-
therapy was successfully phased out from public health
facilities, however, the availability of recommended first-
line (AS+SP) and second-line (AL) therapies was subopti-
mal. Malaria diagnostic capacities were present at half of
the facilities largely dependent on the availability of
malaria microscopy. There is an important gap in the
health workers and health facility coverage with the in-ser-
vice training, job aids and in particular with malaria
related supervisory activities. With respect to case-man-
agement practices less than half of febrile patients are cur-
rently tested, however at facilities with available
diagnostics the testing rates were reasonably high with
two-thirds of the patients tested for malaria. The prevail-
ing treatment practice for test positive patients is in line
with national protocols recommending AS+SP, however
worryingly one-quarter of the patients is treated with
injectable artemether monotherapy. The relatively low
prescription rates of antimalarial treatments for test nega-
tive patients compared to other countries are encouraging.
Yet ACT dispensing and counseling practices were largely
suboptimal. Overall, at all health facilities 35% of febrile
patients were tested and treated according to test result
while at facilities with available commodities 51% of febrile
patients met the same criteria. Future qualitative research
is required to better understand deficiencies of the supply
chain and clinical practices and the forthcoming large
scale implementation of RDTs, using the findings of this
survey and pending qualitative research, should present an
opportunity not only to expand coverage of testing capaci-
ties to the facilities where malaria diagnostics are currently
not available, but also to implement effective support
package of the interventions to bridge the health systems
gaps and do further corrective measures to mainstream
the recommended case-management. However, the ade-
quate availability of ACTs and diagnostics at the point of
care will ultimately determine the success of case-manage-
ment policies in Sudan.
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